Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy. Homo sapiens

This study was conducted to identify transcriptional profiles predictive of a clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy. Overall design: Endoscopic biopsy samples were collected from CF-treated metastatic gastric cancer patients prior to therapy and following the development of resistance to therapy.